Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

8,942 stories indexed, page 97 of 150

🌍Mediaphillipsmedisize.com

Optimize Medical Device Design with Magnesium Thixomolding

Phillips MedisizeOriginal source
🌍Deviceschembio.com

Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

Chembio Diagnostics, Inc.Original source
🇺🇸Industrydyne-tx.com

Rare Disease Day 2023 - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🇺🇸Researchforesitecapital.com

On-Site with Foresite: Meet Michael Rome

Foresite CapitalOriginal source
🌍Mediaphillipsmedisize.com

Metal Injection Molding Makes a Big Impact on Small Parts

Phillips MedisizeOriginal source
🇨🇦Researchucalgary.ca

Student group champions accessibility pilot project in lecture halls

University of CalgaryOriginal source
🇬🇧Industrygenialcompliance.com

First online iPassport User Group a great success - Genial

Genial Genetics (Pathozoom AI)Original source
🌍Industryperspective.com

Perspective shares BOD Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source
🇧🇪Regulatoryfamhp.be

FAMHP reminds of need for customer declaration for buyers of category 1 or 2 chemicals

FAMHP (Belgium)Original source
🌍Industryblueprintgenetics.com

Our service hours during the holiday season

Blueprint Genetics (Quest Diagnostics)Original source
🌍Industrycytomx.com

Results of a phase 2 study of praluzatamab ravtansine (CX-2009) in patients with advanced breast cancer (ABC)

CytomX TherapeuticsOriginal source
🇺🇸Industrydyne-tx.com

FORCE-for-Good-Service-Day-2022 - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🇺🇸CDMOveranex.com

Veranex Acquires Fusion Biotec to Continue Accelerating MedTech Diagnostic Solutions

VeranexOriginal source
🌍Industryperspective.com

Perspective shares CEO Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source
🌍Industryonkuretherapeutics.com

OnKure Therapeutics Appoints Robbie Alton, Pharm., as Vice President of Clinical Operations

OnKure TherapeuticsOriginal source
🇺🇸Industrydyne-tx.com

DM1 Story - BillyDean - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🇫🇷Industrypierre-fabre.com

Creation of the Green Impact Index Consortium

Pierre FabreOriginal source
🇺🇸Researchcidrap.umn.edu

Remdesivir, steroids tied to better COVID hospital outcomes

CIDRAPOriginal source
🇺🇸Industrydyne-tx.com

DM1 Story - Joachim - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🇺🇸Industrydyne-tx.com

DM1 Story - Loraine - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🇺🇸Industrydyne-tx.com

DMD Story - Ravi - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🌍Industrycytomx.com

CX-801, Conditionally Activatable Interferon-alpha 2b Improves Tolerability and Exhibits Preferential Activity in Tumors

CytomX TherapeuticsOriginal source
🇺🇸CDMOnoramco.com

Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

NoramcoOriginal source
🌍Industryq32bio.com

Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of ADX-914 for Atopic Dermatitis

Q32 BioOriginal source
🇬🇧Researchhdruk.ac.uk

Tim Ferris, Jenny Harries and Mauricio Barreto confirmed to join HDR UK’s Annual Scientific Conference

Health Data Research UKOriginal source
🌍Industryq32bio.com

Q32 Bio, a Clinical Stage Biotechnology Company Focused on Therapeutics that Restore Immune Homeostasis, Announces CEO Transition

Q32 BioOriginal source
🇺🇸Researchforesitecapital.com

In Memoriam – Stephen Kaldor

Foresite CapitalOriginal source
🇺🇸Industrydyne-tx.com

joachim and tim

Dyne TherapeuticsOriginal source
🇺🇸Industrynurabio.com

Nura Bio reports preclinical data validating a conserved mechanism of inhibition of NAD hydrolases implicated in neurodegeneration in NEURON Nura Bio™

Nura BioOriginal source
🇺🇸Industrynurabio.com

Marc Freeman wins first annual Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative HealingNura Bio™

Nura BioOriginal source
🌍Industrycytomx.com

Tailoring the Selection of Target, Payload, and Tumor Type to Maximize the Therapeutic Index of Conditionally Activated ADCs

CytomX TherapeuticsOriginal source
🇺🇸Industrydyne-tx.com

diana and jordan 2022

Dyne TherapeuticsOriginal source
🌍Deviceschembio.com

Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay

Chembio Diagnostics, Inc.Original source
🇺🇸Industrysirnaomics.com

Sirnaomics to Present at 3rd Annual Jefferies Asia Forum | Sirnaomics

SirnaomicsOriginal source
🇺🇸Industrydyne-tx.com

rdd2022

Dyne TherapeuticsOriginal source
🇺🇸Industrysirnaomics.com

Sirnaomics Advances GalAhead™-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

SirnaomicsOriginal source
🌍Industryomniab.com

Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

OmniAbOriginal source
🇬🇧Industrygenialcompliance.com

Most common risks to accreditation during inspection - Genial

Genial Genetics (Pathozoom AI)Original source
🇺🇸Industrysirnaomics.com

Sirnaomics' 2022 interim results presentation will be held on 31 August 2022 | Sirnaomics

SirnaomicsOriginal source
🇺🇸Industrysirnaomics.com

Sirnaomics becoming a Constituent of Hang Seng Family of Indexes | Sirnaomics

SirnaomicsOriginal source
🌍Industryq32bio.com

Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

Q32 BioOriginal source
🇺🇸Industrysirnaomics.com

Sirnaomics Develops Peptide Docking Vehicle (PDoV™) Designed for an Enhanced GalNAc Delivery Platform for Novel siRNA Therapeutics | Sirnaomics

SirnaomicsOriginal source
🌍Mediaphillipsmedisize.com

Alzheimer’s Disease: Navigating the Challenging Journey to a Cure

Phillips MedisizeOriginal source
🇺🇸Industrydyne-tx.com

world fshd day 2022

Dyne TherapeuticsOriginal source
🇬🇧Industrygenialcompliance.com

Genial's White Paper on Risk - Genial

Genial Genetics (Pathozoom AI)Original source
🌍Industryq32bio.com

Q32 Bio Presents New Preclinical Data at the International Society of Nephrology Frontiers Meeting Demonstrating the Therapeutic Potential of ADX-097

Q32 BioOriginal source
🌍Industryonkuretherapeutics.com

OnKure Therapeutics Appoints Kevin S. Litwiler, Ph.D., as Senior Vice President of DMPK and Clinical Pharmacology

OnKure TherapeuticsOriginal source
🌍Industryq32bio.com

Shelia Violette, Founder and Chief Scientific Officer of Q32 Bio, to Present at the Keystone Symposia “Resolution of Inflammation” Conference

Q32 BioOriginal source
🌍Industryblueprintgenetics.com

New research collaboration helps shorten the path to diagnosis for rare disease patients through analysis of biobank samples

Blueprint Genetics (Quest Diagnostics)Original source
🌍Industryonkuretherapeutics.com

OnKure Therapeutics Announces First Patient Dosed in the Phase 1b/2 Nautilus Trial of OKI-179 in Combination with Binimetinib in Patients with Advanced NRAS-Mutated Melanoma

OnKure TherapeuticsOriginal source
🇺🇸Researchforesitecapital.com

Thoughts on the Affinivax Acquisition

Foresite CapitalOriginal source
🌍Industrycerbios.swiss

New additional R&D laboratory unit

Cerbios-Pharma SAOriginal source
🌍Regulatoryapifarma.pt

Comentário em Formação e Educação por Apifarma - Contactos E Localização - Apifarma

APIFARMA PortugalOriginal source
🌍Industryblueprintgenetics.com

Blueprint Genetics, a quality leader in genetic testing, embraces new EU regulation (IVDR)

Blueprint Genetics (Quest Diagnostics)Original source
🌍Regulatoryapifarma.pt

Comentário em Áreas de intervenção por Novo Membro – Apifarma - Informar - Portal de Cursos de Formação Profissional

APIFARMA PortugalOriginal source
🇺🇸Industrysirnaomics.com

Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summit

SirnaomicsOriginal source
🌍Industrycerbios.swiss

Pharma Tech Outlook – Top 10 EU CMO’s 2022 – Cerbios Cover Story (April 2022)

Cerbios-Pharma SAOriginal source
🌍Industrycooperpharma.ma

Actions terrain auprès des pharmaciens et des médecins

Cooper Pharma MoroccoOriginal source
🌍Industrycooperpharma.ma

Produits soutenus par des unités opérationnelles et des réseaux de médecins spécialisées

Cooper Pharma MoroccoOriginal source